XML 65 R50.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segment Information Business Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Mar. 31, 2021
Segment Reporting Information [Line Items]          
Revenues $ 1,196,985 $ 756,132 [1] $ 2,165,407 $ 1,425,064 [1]  
Segment operating income 116,503 141,263 [1] 130,827 257,079 [1]  
Restructuring Charges 210 (76) 224 90  
Amortization of acquired intangible assets 74,791 21,955 116,531 39,455  
Business Combination, Acquisition Related Costs [2] 17,404 1,135 158,400 2,421  
Impact of TCJA 159 384 110 554  
Net loss on divestiture of businesses (15) (5) 404 5 [1]  
Amortization of inventory and property step-up to fair value 69,486 714 94,276 1,317  
COVID-19 incremental costs 0 4,539 0 13,209  
Assets 11,752,448   11,752,448   $ 6,574,471
Property, Plant and Equipment, Net 1,511,255   1,511,255   1,235,400
Life Sciences          
Segment Reporting Information [Line Items]          
Revenues 132,327 115,658 253,798 232,570  
Segment operating income 57,519 46,433 106,607 94,894  
Applied Sterilization Technologies          
Segment Reporting Information [Line Items]          
Revenues 204,892 169,547 413,794 321,909  
Segment operating income 99,789 76,835 201,716 140,790  
Assets 3,029,090   3,029,090   2,974,289
Corporate          
Segment Reporting Information [Line Items]          
Segment operating income (71,552) (58,155) (146,612) (110,522)  
Segment operating income          
Segment Reporting Information [Line Items]          
Revenues 1,196,985 756,132 2,165,407 1,425,064  
Segment operating income 278,538 169,909 500,772 314,130  
Healthcare [Member] [Member]          
Segment Reporting Information [Line Items]          
Revenues 744,134 470,927 1,346,951 870,585  
Segment operating income 160,390 104,796 296,550 188,968  
Healthcare and Life Sciences [Member]          
Segment Reporting Information [Line Items]          
Assets 5,398,177   5,398,177   3,600,182
Dental          
Segment Reporting Information [Line Items]          
Revenues 115,632 0 150,864 0  
Segment operating income 32,392 0 42,511 0  
Assets $ 1,175,354   $ 1,175,354   0
Dental | Revenue Benchmark | Customer Concentration Risk          
Segment Reporting Information [Line Items]          
Concentration Risk, Percentage 40.60%   39.50%    
Other foreign locations [Member]          
Segment Reporting Information [Line Items]          
Revenues $ 324,442 189,593 $ 591,669 352,444  
UNITED STATES          
Segment Reporting Information [Line Items]          
Revenues 852,497 549,449 1,531,747 1,041,157  
Property, Plant and Equipment, Net 881,069   881,069   673,784
UNITED KINGDOM          
Segment Reporting Information [Line Items]          
Revenues 20,046 17,090 41,991 31,463  
Property, Plant and Equipment, Net 53,784   53,784   52,140
Other Foreign Entities [Member]          
Segment Reporting Information [Line Items]          
Property, Plant and Equipment, Net 576,402   576,402   $ 509,476
Consumable revenues [Member] | Life Sciences          
Segment Reporting Information [Line Items]          
Revenues 61,748 55,793 118,284 114,635  
Consumable revenues [Member] | Healthcare [Member] [Member]          
Segment Reporting Information [Line Items]          
Revenues 270,089 122,797 476,781 206,551  
Sales Revenue, Services, Net [Member] | Life Sciences          
Segment Reporting Information [Line Items]          
Revenues 36,393 30,624 68,583 58,264  
Sales Revenue, Services, Net [Member] | Healthcare [Member] [Member]          
Segment Reporting Information [Line Items]          
Revenues 271,640 216,457 516,875 404,279  
Capital equipment revenues [Member] | Life Sciences          
Segment Reporting Information [Line Items]          
Revenues 34,186 29,241 66,931 59,671  
Capital equipment revenues [Member] | Healthcare [Member] [Member]          
Segment Reporting Information [Line Items]          
Revenues $ 202,405 $ 131,673 $ 353,295 $ 259,755  
[1] Certain amounts have been adjusted to reflect the change in inventory accounting method, as described in our Annual Report on Form 10-K filed with the SEC on May 28, 2021.
[2] COVID-19 PandemicThe COVID-19 pandemic began to impact our business late in fiscal 2020. The pandemic and related public health recommendations and mandated precautions to mitigate the spread of COVID-19, including deferral of surgical procedures and treatments and shelter-in-place orders or similar measures, negatively affected some of our operations, which impacted our operating results, financial position and cash flows. We have experienced and expect to continue to experience unpredictable fluctuations in demand for certain of our products and services. Also, the COVID-19 pandemic has caused and continues to cause disruptions in our supply chain and labor scarcity resulting in material and labor cost inflation. External factors such as policymaker decisions to remove certain restrictions, as they evaluate the continued infection rate and COVID-19 related deaths, the emergence of new variants of the virus, and the distribution of available vaccines create uncertainty regarding future demand from our Customers and the ability of our suppliers to meet our demands. However, order momentum has continued to improve and increased demand for certain capital equipment products strengthened from the fourth quarter of fiscal 2021.